Accessibility Menu
Elekta Ab (publ) logo

Elekta Ab (publ)(OTC) EKTAF

Market Cap$1.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)-58%
5 Year-58%
1 Year+9%
1 Month+3%
$5.18
+0.00%
+0.00Today
Elekta Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 5.182026-07-31
Elekta Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.34%USD 5.252026-07-06
1 month+2.78%USD 5.042026-06-29
3 month-14.66%USD 6.072026-04-10
Year to date-13.89%USD 6.022025-12-30
1 year+8.62%USD 4.772025-07-29
3 year-29.17%USD 7.312023-07-27
5 year-58.09%USD 12.362021-07-29
Since inception-57.94%USD 12.482003-08-22

Elekta Ab (publ) Financials at a Glance

Market Cap

$1.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 16.67B

Net Income (TTM)

-SEK 513.33M

EPS (TTM)

-$0.15

P/E Ratio

-34.24

Dividend

$0.26

Beta (Volatility)

0.28 (Low)

Price

$5.18

Volume

2,050

Open

$5.18

Previous Close

$5.18

Daily Range

$5.18 - $5.18

52-Week Range

$4.48 - $6.83

Estimated Earnings Date

Aug 27, 2026

EKTAF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elekta Ab (publ)

Elekta AB (publ) is a global medical technology enterprise specializing in advanced clinical tools for cancer and neurological treatment. Established in 1972 and headquartered in Stockholm, Sweden, Elekta offers a comprehensive range of innovative solutions designed to enhance patient care and treatment outcomes.

Products and Services
  • Leading radiotherapy solutions, including Versa HD and Elekta Unity MR-Linac
  • Comprehensive treatment management systems like MOSAIQ Plaza and Elekta Axis Cloud
  • Advanced neurosurgery products, including the Leksell Gamma Knife series
Growth Outlook
  • Recent quarterly revenue reached SEK 4.73 billion, indicating strong market demand
  • Continued investment in R&D, with SEK 1.23 billion allocated in the latest quarter
  • Expansion into emerging markets expected to drive future revenue growth
Financial Highlights
  • Trailing twelve months (TTM) revenue of SEK 18.3 billion, reflecting a solid performance
  • Net income for the latest quarter reported at SEK -860 million, highlighting current challenges
  • Dividend yield of approximately 4.98%, providing potential income for investors
Elekta AB (publ) operates in the medical devices sector, focusing on innovative technologies that address critical healthcare needs. The company's extensive product portfolio includes advanced radiotherapy systems and treatment management solutions, which are essential for multidisciplinary cancer care. Despite facing recent financial challenges, Elekta's commitment to research and development positions it well for future growth. The company's strategic focus on expanding into emerging markets and enhancing its product offerings is expected to drive revenue growth in the coming years. With a solid dividend yield, Elekta presents an intriguing opportunity for investors interested in the healthcare technology sector.
AI Generated • Jul 27, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,102

CEO

Jakob Just-Bomholt

Website

www.elekta.com

Headquarters

Stockholm, SD 103 93, SE

EKTAF Financials

Key Financial Metrics (TTM)

Gross Margin

37.39%

Operating Margin

5.29%

Net Income Margin

-3.10%

Return on Equity

-6.37%

Return on Capital

3.00%

Return on Assets

-1.93%

Earnings Yield

-2.92%

Dividend Yield

4.99%

Payout Ratio

-1.77%

Stock Overview

Market Cap

$1.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

382.08M

Volume

2.05K

Avg. Volume

200.857

Financials (TTM)

Gross Profit

SEK 6.23B

Operating Income

SEK 876.93M

EBITDA

SEK 1.27B

Operating Cash Flow

SEK 1.88B

Capital Expenditure

-SEK 346.85M

Free Cash Flow

SEK 1.54B

Cash & ST Invst.

SEK 3.17B

Total Debt

SEK 7.33B

Elekta Ab (publ) Performance Analysis

Elekta Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30SEK 1,614,476,247-1.2%
20242024-04-30SEK 1,702,409,8715.4%
20252025-04-30SEK 1,706,628,4650.2%
20262026-04-30SEK 1,780,004,6264.3%
Elekta Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31-29.3%
Q22025-10-3111.6%
Q32026-01-313.8%
Q42026-04-3012.0%
Elekta Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30SEK 0.24-30.5%
20242024-04-30SEK 0.3235.7%
20252025-04-30SEK 0.06-81.6%
20262026-04-30SEK -0.14N/A
Elekta Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-07-31127.7%
Q22025-10-31114.3%
Q32026-01-31-95.7%
Q42026-04-30-8864.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

SEK 4.73B

-8.2%

Gross Profit

SEK 1.87B

-8.9%

Gross Margin

39.52%

N/A

Market Cap

$1.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$435.85K

N/A

Employees

4,541

N/A

Net Income

-SEK 860.30M

-122.9%

EBITDA

SEK 68.55M

-44.7%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

SEK 3.17B

+7.2%

Total Debt

SEK 7.33B

-3.1%

Accounts Receivable

SEK 6.99B

-9.3%

Inventory

SEK 2.86B

+3.7%

Long Term Debt

SEK 4.14B

-42.2%

Short Term Debt

SEK 3.19B

+676.9%

Return on Assets

-1.93%

N/A

Return on Invested Capital

7.44%

N/A

Free Cash Flow

SEK 1.33B

+6.8%

Operating Cash Flow

SEK 1.37B

-12.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
RTEZRest Ez Inc.
$70.00+0.00%
GENSFGenus plc
$31.07+0.00%
GTBIFGreen Thumb Industries Inc.
$7.10+1.28%
BOEUFBonesupport Holding AB (publ)
$20.49+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$200.75+0.03%
AAPLApple
$308.91-0.07%
AMZNAmazon
$271.58+0.15%
INTCIntel
$90.20-0.01%

Questions About EKTAF

What is the current price of Elekta Ab (publ)?

Elekta Ab (publ) is trading at $5.18 per share.

What is the 52-week range for Elekta Ab (publ)?

Over the past 52 weeks, Elekta Ab (publ) has traded between $4.48 and $6.83.

How much debt does Elekta Ab (publ) have?

As of the most recent reporting period, Elekta Ab (publ) reported total debt of SEK 792.38M.

How much cash does Elekta Ab (publ) have on hand?

Elekta Ab (publ) reported SEK 344.69M in cash and cash equivalents in its most recent financial results.

What is Elekta Ab (publ)’s dividend yield?

Elekta Ab (publ) currently has a dividend yield of 4.99%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services